NIMO กำลังจะจัดงาน NIMO WAVE LIVE SHOW เป็นครั้งแรกที่งานThailand Game Showby September 30, 2024PR Newswire
Queclink Unveils the GL601 Solar-Powered Asset Tracker for Seamless Intermodal Transportationby September 30, 2024PR Newswire
มหาวิทยาลัย Tongji จัดการประชุมหัวข้อ “ความร่วมมือและแนวโน้มการพัฒนาที่ยั่งยืนในยุคใหม่” ที่กรุงปารีสby September 30, 2024PR Newswire
The Global AI Defense Challenge 2024 Launched with Over $75,000 in Prizesby September 30, 2024PR Newswire
Akeso’s Cadonilimab Receives Second Indication Approval from NMPA for First-Line Treatment of Gastric/GEJ Cancer in All-Comers Populationby September 30, 2024PR Newswire
IASO Bio Scientist and Leading Chinese Physicians in Onco-Hematology Visit Hematology Center at the State University of Campinas, Brazil, to Explore Cooperation in Cancer Treatmentby September 30, 2024PR Newswire
C-Crete Technologies Pours World’s First Granite-Based Concrete – Free of Portland Cement and CO2 Emissions – at Manhattan Supertall Buildingby September 30, 2024PR Newswire
International students amazed by local tradition, culture in visit to Gaoyang, CNS reportby September 30, 2024PR Newswire
Gore Street Capital Successfully Completes Fundraising Round for Japan’s Inaugural Energy Storage Fund, in Partnership with the ITOCHU Corporationby September 30, 2024PR Newswire
Global journalists, influencers explore legacy of Confucius in Shandongby September 30, 2024PR Newswire
Khabib Nurmagomedov’s First Step in Indonesia with Kahforward Inspires Youth to Take Impactful Actionby September 30, 2024PR Newswire
India’s luxury beauty market presents massive growth potential amid unique challenges, finds report by Kearney and LUXASIAby September 30, 2024PR Newswire
Matrixport Expands Footprint in Europe with Acquisition of Swiss-based Crypto Finance Asset Managementby September 30, 2024PR Newswire
From Boomers to Zoomers: how retailers and eCommerce firms can boost sales and loyaltyby September 30, 2024PR Newswire
Regor Enters into a Definitive Purchase Agreement for Genentech to Acquire Regor’s Portfolio of next-generation CDK inhibitors for the Treatment of Breast Cancerby September 30, 2024PR Newswire
